2Mauleou D.Preclinical and clinical development of dexketoprofen.Drugs.1996.52(suppl 5):24.
3ChP(中国药典)．2000．Vol Ⅱ(二部)：549
二级参考文献5
1[1]Mauleon D.Preclinical and clinical development of dexketoprofen.Drugs,1996，52(Suppl 5):24.
2[2]Castellani L,Flieger M,Sinibaldi M.Enantiomer separation of 2-arylpropionic acid on an ergot alkaloid-based stationary phase mircobore column application.J Liq Chromatogr,1994,17(17):3695.
3[3]Maitre JM,Boss G,Testa B.HPLC separation of enantiomers of anti-inflammatory α-arylpropionates:suitablity of the method for iv vitro metabolic studies.J Chro matogr,1984,299:397.
4[4]Hayball PJ,Nation RL,Bochner F.Enantiospecific analysis of Ketoprofen in plasma by HPLC.J Chromatogr,1991,570:446.
5[5]VanGiessen GJ,Kaiser DG.GLC determination of Ibuprofen[dl-2-(p-Isobatylphenyl) propionic acid].J Pharm Sci,1975,64:798.
2Tegeder I,Lotsch J,Schippers MK,et al.Comparison of tissue concentrations after intramuscular and topical administration of ketoprofen[J].Pharm Res,2001,18(7):980-986.
3Rautio J,Taipale H,Gynther J,et al.In vitro evaluation of acyloxyalkyl esters as demal prodrugs of ketoprofen and naproxen[J].J Pharm Sci,1998,87(12):1622-1628.
4Bonina FP,Puglia C,Barbuzzi T,et al.In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen,naproxen and diclofenac[J].Eur J Pharm Sci,2001,14(2):123-134.
5Kommuru TR,Khan MA,Reddy IK.Racemate and enantiomers of ketoprofen:phase diagram,thermodynamic studies,skin permeability,and use of chiral permeation enhancers[J].J Pharm Sci,1998,87(7):833-840.
7Brune K. Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti - inflammatory drugs[J]. Drugs, 1990,40(Suppl 5) :12.
